人類肝臟模型市場規模、佔有率和成長分析（按產品類型、應用、最終用戶和地區分類）—2025-2032年產業預測

全球人類肝臟模型市場規模預計在 2023 年達到 12 億美元，從 2024 年的 13.8 億美元成長到 2032 年的 41.2 億美元，在預測期（2025-2032 年）內複合年成長率為 14.7%。

全球人工肝模型市場正受益於藥物毒性測試需求的成長以及動物實驗的減少。再生醫學領域投資的不斷增加，以及3D肝臟模型技術的進步，正在推動製藥和生物技術領域精準藥物測試替代方案的發展。肝臟相關疾病的普遍性進一步激發了人們對個人化醫療的興趣。然而，先進肝臟建模技術高成本、熟練專業人員短缺以及模型本身的複雜性等挑戰可能會阻礙市場成長。此外，監管方面的挑戰和模型檢驗的不一致也可能限制其在整個行業的應用，從而影響市場滲透率和各地區的預期成長。

全球人工肝模型市場促進因素

對藥物毒性進行精準快速評估的需求日益成長，是推動全球人類肝臟模型市場成長的主要動力。這些模型具有更高的生理相關性和更優的預測準確性，使製藥公司能夠在研發早期階段就發現潛在的毒性。因此，候選藥物可以更有信心地推進開發平臺。這種能力不僅簡化了藥物評估流程，還提高了研究結果的整體可靠性，從而促進了製藥業的創新和效率提升。向更先進的調查方法的轉變凸顯了人類肝臟模型在現代藥物研發中的重要性。

全球人類肝臟模型市場限制因素

全球人類肝臟模型市場面臨先進肝臟模型（例如晶片肝臟技術和3D列印組織）生產和永續性的挑戰。專用設備、高技能人員和高品質材料所需的資金可能非常龐大。這造成了成本負擔和進入門檻，尤其對於預算有限的小規模實驗室和機構而言更是如此。因此，這種經濟負擔阻礙了市場擴張，限制了發展中地區獲得最尖端科技的機會，最終限制了肝臟研究及相關應用領域的發展潛力。

全球人類肝臟模型市場趨勢

受3D生物列印和晶片器官技術突破性進展的推動，全球人類肝臟模型市場正經歷顯著成長。這些創新提高了藥物篩檢流程的準確性，減少了對動物實驗的依賴，並使研究人員能夠高精度地模擬複雜的肝臟疾病。這項進步不僅加速了藥物發現和開發，還有助於實現個人化治療策略。隨著研究人員對更先進、更可靠的人體相關模型的需求不斷成長，對先進肝臟模型的需求預計將持續增加，從而推動該市場顯著擴張，並吸引來自生物醫學領域各行業的投資。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 二手資料和一手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場概覽
• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2024）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 技術評估
• 監管環境

人類肝臟模型市場規模（按產品類型和複合年成長率分類）（2025-2032 年）

• 市場概覽
• 2D模型
• 3D模型
• 晶片肝臟/微流體模型
• 離體/組織切片模型

人類肝臟模型市場規模（按應用及複合年成長率分類）（2025-2032 年）

• 市場概覽
• ADME 測試
• 毒理學/安全性測試
• 疾病建模
• 其他

人類肝臟模型市場規模（按最終用戶分類）及複合年成長率（2025-2032 年）

• 市場概覽
• 製藥和生物技術公司
• 合約研究組織（CRO）
• 學術和研究機構

人類肝臟模型市場規模及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2024 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2024 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2022-2024年營收年比比較

主要企業簡介

• ATCC
• Merck KGaA
• AcceGen
• ZenBio, Inc.
• Organovo Holdings Inc.
• BioIVT
• InSphero
• CN Bio Innovations Ltd.
• STEMCELL Technologies
• ScienCell Research Laboratories, Inc.
• Emulate, Inc.
• Cyfuse Biomedical KK
• Mimetas
• Cellink
• PhoenixBio Co., Ltd.
• Thermo Fisher Scientific Inc.
• BICO Group
• Kirkstall Ltd.
• MATTEK（The BICO Group）
• HiREL

結論與建議

Global Human Liver Models Market size was valued at USD 1.2 billion in 2023 and is poised to grow from USD 1.38 billion in 2024 to USD 4.12 billion by 2032, growing at a CAGR of 14.7% during the forecast period (2025-2032).

The market for global human liver models is gaining momentum, driven by an increasing demand for drug toxicity testing and a shift towards reducing animal experimentation. The rise in investments in regenerative medicine, along with advancements in 3D liver models, enhances the development of precise drug testing alternatives in the pharmaceutical and biotechnology sectors. The prevalence of liver-related diseases further fuels interest in personalized medicine. However, challenges such as high costs of advanced liver model technologies, a shortage of skilled professionals, and the complexity associated with these models can hinder growth. Additionally, regulatory challenges and inconsistencies in model validation may restrict broader industry adoption, impacting market penetration and forecasted growth in various regions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Human Liver Models market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Human Liver Models Market Segments Analysis

Global Human Liver Models Market is segmented by Product Type, Application, End-User and region. Based on Product Type, the market is segmented into 2D Models, 3D Models, Liver-on-a-Chip / Micro-fluidic Models and Ex-Vivo / Tissue Slice Models. Based on Application, the market is segmented into ADME Studies, Toxicology / Safety Testing, Disease Modelling and Others. Based on End-User, the market is segmented into Pharmaceutical & Biotechnology Companies, Contract Research Organisations (CROs) and Academic & Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Human Liver Models Market

The increasing need for precise and prompt assessment of drug toxicity significantly propels the growth of the global human liver models market. These models provide enhanced physiological relevance and improved predictive accuracy, enabling pharmaceutical companies to detect potential toxicity at earlier stages of development. As a result, drug candidates can advance through the development pipeline with greater assurance. This capability not only streamlines the drug evaluation process but also enhances the overall reliability of findings, thereby fostering innovation and efficiency within the pharmaceutical industry. The shift toward more sophisticated testing methodologies underscores the importance of human liver models in modern drug development.

Restraints in the Global Human Liver Models Market

The Global Human Liver Models market faces challenges related to the production and sustainability of sophisticated liver models, including liver-on-a-chip technologies and three-dimensional printed tissues. The financial investment needed for specialized equipment, a highly skilled workforce, and quality materials can be substantial. This creates barriers, particularly for smaller laboratories or institutions operating with limited budgets, as the costs can be overwhelming. Consequently, this financial strain hinders the market's expansion and reduces access to cutting-edge technologies in less developed areas, ultimately limiting the potential for advancements in liver research and related applications.

Market Trends of the Global Human Liver Models Market

The Global Human Liver Models market is witnessing significant growth driven by breakthroughs in 3D bioprinting and organ-on-a-chip technologies. These innovations enhance the precision of drug screening processes and diminish reliance on animal testing, offering researchers the ability to replicate intricate liver diseases with high fidelity. This evolution not only accelerates drug discovery and development but also supports tailored therapeutic strategies. As researchers increasingly seek more sophisticated and reliable human-relevant models, the demand for advanced liver models is expected to rise, positioning this market for notable expansion and attracting investments from various sectors within the biomedical landscape.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technology Assessment
• Regulatory Landscape

Global Human Liver Models Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• 2D Models
• 3D Models
• Liver-on-a-Chip / Micro-fluidic Models
• Ex-Vivo / Tissue Slice Models

Global Human Liver Models Market Size by Application & CAGR (2025-2032)

• Market Overview
• ADME Studies
• Toxicology / Safety Testing
• Disease Modelling
• Others

Global Human Liver Models Market Size by End-User & CAGR (2025-2032)

• Market Overview
• Pharmaceutical & Biotechnology Companies
• Contract Research Organisations (CROs)
• Academic & Research Institutes

Global Human Liver Models Market Size & CAGR (2025-2032)

• North America (Product Type, Application, End-User)
  • US
  • Canada
• Europe (Product Type, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• ATCC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AcceGen
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ZenBio, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organovo Holdings Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioIVT
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InSphero
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CN Bio Innovations Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• STEMCELL Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ScienCell Research Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emulate, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyfuse Biomedical K.K.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mimetas
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cellink
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PhoenixBio Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BICO Group
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Kirkstall Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MATTEK (The BICO Group)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HiREL
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations